Close
NetAlly Unveils Next Generation LinkRunner® AT Network and Cable Testers Jun 3, 2024 12:02AM

In-depth AutoTest provides unmatched visibility for Ethernet cable and network link validation and troubleshooting

LAS VEGAS, June 03, 2024 (GLOBE NEWSWIRE) -- Today at the Cisco Live! event, NetAlly announced the availability of its next-generation LinkRunner® AT network and cable testers, continuing a twenty-plus year legacy of innovative troubleshooting tools for network engineers and technicians.

The LinkRunner AT 3000 delivers fast and comprehensive validation... (continue reading...)


IXOPAY Appoints Brady Harris as CEO to Drive Global Payments Growth Jun 3, 2024 12:00AM

Following the IXOPAY and TokenEx merger, new leadership strengthens the company’s market position and serves the evolving needs of customers

TULSA, Okla., June 03, 2024 (GLOBE NEWSWIRE) -- Today, IXOPAY, announced the appointment of industry veteran Brady Harris as its new CEO. His appointment aligns with the recent merger of IXOPAY and TokenEx, highlighting a significant shift in the payments industry towards a multi-processor payment model, which empowers merchants... (continue reading...)


BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage Jun 3, 2024 12:00AM

PRESS RELEASE

BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage

  • The seed round was co-led by UI Investissement (via the Pertinence Invest 2 Fund, advised by Mérieux Equity Partners), Elaia and GO Capital, with participation from one major ophthalmology player, Unither Pharmaceuticals and HTL Biotechnology, the global leader in production and development of pharma grade biopolymers.
  • Proceeds to... (continue reading...)

AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences Jun 2, 2024 11:01PM

— AMD Ryzen™ AI 300 Series Processors Unlock Transformational AI Experiences for Windows Copilot+ PCs

— AMD Ryzen™ 9000 Series Processors Set New Standards in Efficiency, Performance, and Content Creation —

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- Today, during Computex 2024, AMD (NASDAQ: AMD) announced a groundbreaking series of next-generation architecture and products aimed at ushering in a new era of AI experiences. AMD is introducing new... (continue reading...)


AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Roadmap Jun 2, 2024 11:00PM

— Updated AMD Instinct accelerator roadmap brings annual cadence of leadership AI performance and memory capabilities —

— New AMD Instinct MI325X accelerator expected to be available in Q4 2024 with up to 288GB of HBM3E memory; new AMD Instinct MI350 series accelerators based on AMD CDNA 4 architecture expected to be available in 2025 with 35x generational increase in AI inference performance —

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- At... (continue reading...)


More Globe Newswire

View Older Stories

Jun 2, 2024 10:59PM AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen and EPYC Processors at Computex 2024
Jun 2, 2024 10:13PM Flash News: OKX Launches 100% Fee Rebate Campaign
Jun 2, 2024 08:38PM Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial
Jun 2, 2024 08:23PM Mesoblast Corporate Presentation at Investor Conference
Jun 2, 2024 08:00PM HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
Jun 2, 2024 07:00PM Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 2, 2024 06:43PM Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
Jun 2, 2024 05:30PM Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
Jun 2, 2024 05:07PM Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
Jun 2, 2024 12:30PM Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting
Jun 2, 2024 11:31AM KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
Jun 2, 2024 11:31AM KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
Jun 2, 2024 11:27AM Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
Jun 2, 2024 11:27AM Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
Jun 2, 2024 10:55AM Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
Jun 2, 2024 10:00AM Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Across Multiple Cancers and the Ability to Quantify ER Pathway Activation in Breast Cancer from a Simple
Jun 2, 2024 10:00AM ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
Jun 2, 2024 10:00AM Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 The
Jun 2, 2024 09:51AM BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 2, 2024 09:01AM Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2024
Jun 2, 2024 08:56AM NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Enterprise Software Support for NVIDIA IGX With Holoscan
Jun 2, 2024 08:52AM NVIDIA Robotics Adopted by Industry Leaders for Development of Tens of Millions of AI-Powered Autonomous Machines
Jun 2, 2024 08:44AM Robotic Factories Supercharge Industrial Digitalization as Electronic Makers Adopt NVIDIA AI and Omniverse
Jun 2, 2024 08:41AM NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs
Jun 2, 2024 08:35AM Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial Revolution
Jun 2, 2024 08:32AM NVIDIA Supercharges Ethernet Networking for Generative AI
Jun 2, 2024 08:23AM GDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
Jun 2, 2024 08:13AM NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World’s Millions of Developers Into Generative AI Developers
Jun 2, 2024 08:11AM NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI Avatars
Jun 2, 2024 08:00AM Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
Jun 2, 2024 08:00AM William Miller Spearheads Launch of Pioneering OkayCoin Staking Protocol
Jun 2, 2024 08:00AM CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
Jun 2, 2024 04:00AM BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment
Jun 2, 2024 02:00AM ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth
Jun 1, 2024 09:00PM BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm
Jun 1, 2024 08:15PM Heineken® Celebrates Thousands of ‘Real Hardcore Fans’ by Helping Them Take Part in the UEFA Champions League Final Trophy Celebrations For The First Time Ever
Jun 1, 2024 05:10PM National Skills Champions are Honoured at the Skills Canada National Competition 2024, in Québec
Jun 1, 2024 03:00PM First Federal Savings Bank and ICBA Offer Tips to Help Simplify the Homebuying Process
Jun 1, 2024 01:02PM Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort
Jun 1, 2024 12:55PM Union members and allies mark Injured Workers’ Day in locations across Ontario
Jun 1, 2024 12:36PM Prospera Energy Inc. Announces 2023 Financial Results
Jun 1, 2024 10:00AM Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-sma
Jun 1, 2024 10:00AM Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 1, 2024 10:00AM SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical
Jun 1, 2024 09:14AM Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing
Jun 1, 2024 09:00AM ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
Jun 1, 2024 09:00AM Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
Jun 1, 2024 08:15AM FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 1, 2024 08:15AM Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
Jun 1, 2024 08:15AM Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
View Older Stories